A Clinical Study to Evaluate the Pharmacokinetics and the Absolute Bioavailability of SRT2104 Given as a 250mg Oral Suspension and Intravenous Microdose of 100 Âµg Carbon-14 Radio-labeled SRT2104 in Healthy Male Subjects